project id: TCGA-STAD; case submitter id: TCGA-CD-8530; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.61; rna integrity number: 7.9; age at index: 51; days to birth: -18992; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Alive; year of birth: 1960; age at diagnosis: 18992; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 377.0; icd 10 code: C16.1; last known disease status: not reported; morphology: 8145/3; primary diagnosis: Carcinoma, diffuse type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Fundus of stomach; synchronous malignancy: No; tissue or organ of origin: Fundus of stomach; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.9; longest dimension: 1.6; oct embedded: No; shortest dimension: 0.5; portion submitter id: TCGA-CD-8530-01A-11; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 85.0;